Product information

Current status:

Cancelled Post Market

Current status date:

2015-10-26

Original market date: ^{See footnote 1}

1994-12-31

Product name:

RATIO-CLONAZEPAM

DIN:

02103656 Electronic product monograph is not available

Company:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

TARGETED SUBSTANCES (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:12.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N03AE01 CLONAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0111558001